IndraLab
Statements
Moxifloxacin inhibits KCNH2. 30 / 32
2
|
30
reach
"At standard clinical concentrations moxifloxacin induces approximately 5% hERG potassium channel block and 10 ms of QTc prolongation, and in our clinical study a supratherapeutic dose of intravenous moxifloxacin caused a QTc prolongation of 30 ms. At similar concentrations, the iPSC cardiomyocytes did not show statistically significant APDc or FPDc prolongation, but moxifloxacin caused concentration dependent APDc and FPDc prolongation above this range (21-200 muM), and arrhythmias were detected in in both cell types at approximately 50-fold clinical Cmax."